The risk of Rift Valley fever virus introduction and establishment in the United States and European Union
Autor: | Alicia I Rolin, Lea Berrang-Ford, Manisha A. Kulkarni |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2013 |
Předmět: |
Rift Valley fever virus
Epidemiology Range (biology) Immunology Review Biology Microbiology systematic review Environmental protection Virology Drug Discovery medicine media_common.cataloged_instance European Union Rift Valley fever European union Socioeconomics media_common risk General Medicine medicine.disease United States Infectious Diseases Biological warfare Severe morbidity Parasitology |
Zdroj: | Emerging Microbes & Infections |
ISSN: | 2222-1751 |
Popis: | Rift Valley fever virus (RVFV) is an arthropod-borne disease resulting in severe morbidity and mortality in both human and ruminant populations. First identified in Kenya in 1930, the geographical range of RVFV has been largely constrained to the African continent, yet has recently spread to new regions, and is identified as a priority disease with potential for geographic emergence. We present a systematic literature review assessing the potential for RVFV introduction and establishment in the United States (US) and European Union (EU). Viable pathways for the introduction of RVFV include: transport of virus-carrying vectors, importation of viremic hosts and intentional entry of RVFV as a biological weapon. It is generally assumed that the risk of RVFV introduction into the US or EU is low. We argue that the risk of sporadic introduction is likely high, though currently an insufficient proportion of such introductions coincide with optimal environmental conditions. Future global trends may increase the likelihood of risk factors for RVFV spread. |
Databáze: | OpenAIRE |
Externí odkaz: |